Galactomannan Antigen Enzyme-Linked Immunosorbent Assay for Diagnosis of Invasive Aspergillosis after Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 4, 2007, Pages 440-443

  Foy, Patrick C ^a   van Burik, Jo Anne H ^a   Weisdorf, Daniel J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Aspergillus galactomannan antigen; Enzyme linked immunosorbent assay; Hematopoietic stem cell transplantation; Invasive aspergillosis; Pulmonary nodules

Indexed keywords

GALACTOMANNAN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASPERGILLOSIS; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CALCULATION; CHILD; CONTROLLED STUDY; CULTURE TECHNIQUE; CYTOLOGY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; PREDICTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; WHOLE BODY RADIATION;

ASPERGILLOSIS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MANNANS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 33947264365     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.11.014     Document Type: Article

References (18)

1. Patterson T.F., Kirkpatrick W.R., White M., et al., Aspergillus Study Group. Invasive aspergillosis: disease spectrum, treatment practices, and outcomes. Medicine (Baltimore) 79 (2000) 250-260
2. Kontoyiannis D.P., Sumoza D., Tarrand J., et al. Significance of aspergillemia in patients with cancer: a 10-year study. Clin Infect Dis 31 (2000) 188-189
3. Gefter W.B., Albelda S.M., Talbot G.H., et al. Invasive pulmonary aspergillosis and acute leukemia: limitations in the diagnostic utility of the air crescent sign. Radiology 157 (1985) 605-610
4. von Eiff M., Zuhlsdorf M., Roos N., et al. Pulmonary fungal infections in patients with hematological malignancies: diagnostic approaches. Ann Hematol 70 (1995) 135-141
5. Swanink C.M., Meis J.F., Rijs A.J., et al. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 35 (1997) 257-260
6. Ascioglu S., Rex J.H., de Pauw B., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34 (2002) 7-14
7. Maertens J., Van Eldere J., Verhaegen J., et al. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 186 (2002) 1297-1306
8. Herbrecht R., Letscher-Bru V., Oprea C., et al. Aspergillus galactomannandetection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 20 (2002) 1898-1906
9. Blijlevens N.M., Donnelly J.P., Meis J.F., et al. Aspergillus galactomannan antigen levels in allogeneic haematopoietic stem cell transplant recipients given total parenteral nutrition. Transplant Infect Dis 4 (2002) 64-65
10. Aubry A., Porcher R., Bottero J., et al. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. J Clin Microbiol 44 (2006) 389-394
11. Tanriover M.D., Metan G., Altun B., et al. False-positivity for Aspergillus antigenemia related to the administration of piperacillin/tazobactam. Eur J Intern Med 16 (2005) 489-491
12. Bart-Delabesse E., Basile M., Al Jijakli A., et al. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J Clin Microbiol 43 (2005) 5214-5220
13. Walsh T.J., Shoham S., Petraitiene R., et al. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol 42 (2004) 4744-4748
14. Adam O., Auperin A., Wilquin F., et al. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 38 (2004) 917-920
15. Sulahian A., Touratier S., and Ribaud P. False-positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 349 (2003) 2366-2367
16. Viscoli C., Machetti M., Cappellano P., et al. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 38 (2004) 913-916
17. Wald A., Leisenring W., van Burik J.A., et al. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 175 (1997) 1459-1466
18. Maertens J., Theunissen K., Verhoef G., et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 41 (2005) 1242-1250